Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Fusafungin is a depsipeptide antibacterial produced by Fusarium lateritium. It is active against some gram-positive and gram-negative organisms, Candida albicans and Mycoplasma pneumoniae. It is used in aerosol form in the treatment of upper respiratory tract infections (throat and nasal passages), inhaled (nasally or orally).
At latest update, relevant published data on excretion into breast milk were not found.
It is not absorbed and does not appear in the plasma (AEMPS 2013), hence it appearance in the human milk is highly unlikely. In any case, it would not be absorbed by the infant.
Marketed product in many countries though retired licence in others for no proof on effectiveness. (Newsletter WHO 2005)